MDHearing Volt vs Sony CRE-C20

The MDHearing Volt is a budget-priced prescription hearing aid released in 2020, earning a B grade with a SoundScore of 3.0/5 in our lab testing. At $397, it sits in the lowest price tier for prescription devices, ranking #34 of 39 in its category. In our testing, the Volt showed a mixed performance profile with one standout strength: feedback handling scored an excellent 5.0/5, which is 0.28 points above the category average. This means users can expect minimal whistling or squealing during typical wear. However, speech performance was limited, with speech in quiet scoring 1.8/5 (1.65 points below average) and speech in noise at 1.0/5 (1.11 points below average). Own voice comfort was mixed at 2.6/5, roughly matching the category average. Music streaming capability was not functional in our testing, scoring 0.0/5—a significant limitation for users who want to stream audio from their phone. This is 2.76 points below the prescription hearing aid category average. The Volt may appeal to budget-conscious consumers who prioritize basic amplification and feedback-free wear over advanced speech enhancement or streaming features. Those seeking stronger speech performance in the same price range may want to consider alternatives like the RxEars Rxi, which scored 4.07/5 in our testing. The Volt's rechargeable battery and behind-the-ear design offer practical convenience, but its core sound performance reflects its entry-level positioning.

The Sony CRE-C20 is a mid-priced OTC hearing aid with an invisible-in-ear design, available for $999. In our lab testing, it earned a B grade with a SoundScore of 3.5/5, ranking #37 of 65 OTC hearing aids tested. This device shows a notable split in performance. Speech clarity is a clear strength—speech in quiet scores 4.1/5, which is 1.33 points above the category average, and speech in noise scores 2.7/5, sitting 1.24 points above average despite being only mixed in absolute terms. These results suggest the CRE-C20 prioritizes conversational intelligibility in its tuning approach. However, the device has significant limitations. Music streaming scored 0.0/5, falling 1.92 points below the category average—a notable weakness for users who want to stream audio. Feedback handling is solid at 3.9/5, though it sits 0.64 points below the category average of 4.54/5. Own voice comfort is mixed at 2.9/5, slightly above the category average. The CRE-C20 responds well to adjustment, with the normalized score improving from 3.3/5 at initial fit to 4.2/5 when tuned—a 0.9-point gain. Buyers focused primarily on speech understanding in conversations may find value here, but those wanting music streaming or seeking the strongest overall OTC performance should note that several competitors in this price range, including the Sony CRE-E10 at 4.66/5, scored higher in our testing.